UMIN ID: UMIN000001457
Registered date:28/10/2008
The efficacy evaluation of tocilizumab to glucocorticoid-resistant patients with adult Still's disease and systemic juvenile idiopathic arthritis: the open trial
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Adult Still's disease and systemic juvenile idiopathic arthritis |
| Date of first enrollment | 2008/10/01 |
| Target sample size | 10 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Tocilizumab is to be infused every 2 to 4 weeks at 8 mg/kg of body weight |
Outcome(s)
| Primary Outcome | Amount of glucocorticoid-dose tapered after tocilizumab-administration |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 16years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1.pregnant women or women trying to get pregnant 2.patients with dementia 3.patients considered inappropriate judged by attending physicians |
Related Information
| Primary Sponsor | Division of Rheumatology & Clinical Immunology, Jichi Medical University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Masahiro Iwamoto |
| Address | 3311-1 Yakushiji, Shimotsuke, Tochigi Japan |
| Telephone | 0285587358 |
| hiro-iwa@jichi.ac.jp | |
| Affiliation | Jichi Medical University Division of Rheumatology & Clinical Immunology |
| scientific contact | |
| Name | Masahiro Iwamoto |
| Address | 3311-1 Yakushiji, Shimotsuke, Tochigi Japan |
| Telephone | 0285587358 |
| hiro-iwa@jichi.ac.jp | |
| Affiliation | Jichi Medical University Division of Rheumatology & Clinical Immunology |